Home LiteratureArticle Details
PMID: 16884858 Published · ppublish English Case Reports Journal Article

Spindle cell oncocytoma of the adenohypophysis: report of a case with a 16-year follow-up.

Pathology, research and practice ·Vol. 202 ·No. 10 ·2006-00-00 ·Pages 745-50

Vajtai I, Sahli R, Kappeler A

Abstract

Spindle cell oncocytoma (SCO) is a recently described, rare neoplasm of the anterior pituitary. Clinically and radiologically simulating a non-functioning macroadenoma, its eponymous fusiform cells display a non-epithelial phenotype with conspicuous cytoplasmic accumulation of mitochondria. We report a case of SCO retrospectively identified in a biopsy specimen 16 years after transsphenoidal operation of a 48-year-old woman. Presenting symptoms were adynamia and transient decrease of visual acuity. Neuroimaging showed an isointense, enhancing, sellar-centered mass 1.8 cm in diameter without evidence of invasive growth. No postoperative adjuvant therapy was administered. The patient was left with panhypopituitarism, yet no recurrence was seen during follow-up. Initially diagnosed as a null cell adenoma of oncocytic type, repeat immunohistochemistry showed the characteristic coexpression of S100 protein, vimentin, and epithelial membrane antigen. Oncocytic granula stained intensely with antimitochondrial antibody 113-1, and were negative with the lysosomal marker CD68. Anterior pituitary hormones tested negative, and there was no evidence of neuroendocrine differentiation using antibodies to synaptophysin and chromogranin. Few cells stained for glial fibrillary acidic protein (GFAP). SCO has been proposed to represent a neoplasm of folliculo-stellate cells (FSCs). While the dynamic properties of the latter are incompletely characterized, and indeed no specific marker allows for their identification, overlapping features of SCO with look alikes, in particular pituicytoma, point to FSCs being a potential adult stem cell. The favorable outcome of the present case further argues for SCO to be considered a low-grade neoplasm. Moderate tumor size, lack of invasiveness, and low proliferation rate are likely predictors of benign behavior.

MeSH Terms
Adenoma, Oxyphilic/chemistry,pathology,surgery Autoantibodies/analysis Biomarkers, Tumor/analysis Female Fluorescent Antibody Technique, Direct Follow-Up Studies Humans Magnetic Resonance Imaging Middle Aged Mitochondria/immunology Pituitary Gland, Anterior/chemistry,pathology,surgery Pituitary Neoplasms/chemistry,pathology,surgery S100 Proteins/analysis Staining and Labeling Treatment Outcome
Chemicals
Autoantibodies Biomarkers, Tumor S100 Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Vajtai Istvan
Institute of Pathology, University of Bern, Switzerland. [email protected]
Sahli Rahel
Kappeler Andreas
Article Info
Journal
Pathology, research and practice
Abbr.
Pathol Res Pract
ISSN
0344-0338
Published
2006-00-00
Epub
2006-00-01
Pages
745-50
Language
English
Region
Germany
NLM ID
7806109
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]